Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man.

The role of FSH in the maintenance of spermatogenesis in man is poorly understood. To determine whether normal serum levels of FSH are necessary for the maintenance of quantitatively normal spermatogenesis, we first studied the effect on sperm production of selective FSH deficiency induced by chronic administration of hCG in normal men. Then, we determined the effect of FSH replacement in some of these men. After a 3-month control period, eight normal men (aged 30-39 yr) received 5000 IU hCG, im, twice weekly for 7 months. Then while continuing the same dosage of hCG, subjects simultaneously received 200 mg testosterone enanthate (T), im, weekly for an additional 6 months. hCG administration alone resulted in partial suppression of the mean sperm concentration from 88 +/- 24 (+/-SEM) million/ml during the control period to 22 +/- 7 million/ml during the last 4 months of hCG treatment (P less than 0.001 compared to control values). With the addition of T to hCG, sperm counts remained suppressed to the same degree. Except for one man who became azoospermic while receiving hCG plus T, sperm motilities and morphologies remained normal in all subjects throughout the entire study. During both the hCG alone and hCG plus T periods, serum FSH levels were undetectable (less than 25 ng/ml), and urinary FSH levels were comparable to those in prepubertal children and hypogonadotropic hypogonadal adults. We replaced FSH activity in four of the eight men in whom prolonged selective FSH deficiency and partial suppression of sperm production were induced by hCG administration. Immediately after the period of hCG plus T administration, T was stopped in four men who continued to receive hCG alone (5000 IU, im, twice weekly) for 3 months. Then, while continuing the same dosage of hCG, these men received 100 IU human FSH, sc, daily (n = 2) or 75 IU human menopausal gonadotropin, sc, daily (n = 2) for 5-8 months. During the second period of hCG administration alone, serum FSH levels were undetectable (less than 25 ng/ml), and sperm concentrations were suppressed (34 +/- 13 million/ml) compared to the control values for these four men (125 +/- 39 million/ml; P less than 0.001). With the addition of FSH to hCG, FSH levels increased (213 +/- 72 ng/ml) and sperm concentrations rose significantly, reaching a mean of 103 +/- 30 million/ml (P less than 0.03 compared to hCG alone).(ABSTRACT TRUNCATED AT 400 WORDS)

[1]  A. Matsumoto,et al.  Stimulation of sperm production by human chorionic gonadotropin after prolonged gonadotropin suppression in normal men. , 1985, Journal of andrology.

[2]  T. Khalil,et al.  Isolated follicle-stimulating hormone deficiency in men: successful long-term gonadotropin therapy. , 1984, Fertility and sterility.

[3]  A. Matsumoto,et al.  Reinitiation of sperm production in gonadotropin-suppressed normal men by administration of follicle-stimulating hormone. , 1983, The Journal of clinical investigation.

[4]  E. Nieschlag,et al.  Active immunization with follicle-stimulating hormone for fertility control: a 4 1/2-year study in male rhesus monkeys. , 1983, Fertility and sterility.

[5]  J. Schenker,et al.  Treatment of oligoasthenospermia with human chorionic gonadotropin: hormonal profiles and results. , 1983, Fertility and sterility.

[6]  R. Rebar,et al.  Human chorionic gonadotropin and testicular function: stimulation of testosterone, testosterone precursors, and sperm production despite high estradiol levels. , 1983, The Journal of clinical endocrinology and metabolism.

[7]  P. Kelly,et al.  Inhibition of Spermatogenesis and Steroidogenesis During Long-Term Treatment with hCG in the Rat , 1982 .

[8]  M. Sairam,et al.  Control of spermatogenesis in primates: Effects of active immunization against FSH in the monkey , 1982 .

[9]  A. Matsumoto,et al.  Follicle-stimulating hormone and human spermatogenesis. , 1981, The Journal of clinical investigation.

[10]  K. Catt,et al.  Estrogen dependence of a gonadotropin-induced steroidogenic lesion in rat testicular Leydig cells. , 1980, The Journal of clinical investigation.

[11]  E. Siris,et al.  New evidence for intrinsic follicle-stimulating hormone-like activity in human chorionic gonadotropin and luteinizing hormone. , 1978, Endocrinology.

[12]  A. Parlow,et al.  Isolated follicle-stimulating hormone deficiency in man. , 1977, Fertility and sterility.

[13]  H. Kulin,et al.  Timed urinary gonadotropin measurements in normal infants, children, and adults, and in patients with disorders of sexual maturation. , 1977, The Journal of pediatrics.

[14]  H. Kulin,et al.  FSH suppression during short term HCG administration: a gonadally mediated process. , 1972, The Journal of clinical endocrinology and metabolism.

[15]  R. Northcutt,et al.  Follicle-stimulating activity of human chorionic gonadotropin: Further evidence for non-identity with follicle-stimulating hormone. , 1970, The Journal of clinical endocrinology and metabolism.

[16]  C. A. Paulsen,et al.  THE DETERMINATION OF SIZE AND CONCENTRATION OF HUMAN SPERM WITH AN ELECTRONIC PARTICLE COUNTER. , 1965, The Journal of laboratory and clinical medicine.

[17]  W. O. Maddock,et al.  The effects of chorionic gonadotropin in adult men: increased estrogen and 17-ketosteroid excretion, gynecomastia, leydig cell stimulation and semi-niferous tubule damage. , 1952, The Journal of clinical endocrinology and metabolism.

[18]  E. Steinberger,et al.  Hormonal control of spermatogenesis. , 1967 .